Thrombopoietin and Platelet Production in Chronic Immune Thrombocytopenia

Overview

Journal Hematol Oncol Clin North Am

Specialties Hematology
Oncology

Date 2009 Nov 26

PMID 19932428

Citations 22

Authors

David J Kuter

Terry B Gernsheimer

Affiliations

Soon will be listed here.

Abstract

Since 1968, a greater understanding of platelet biology and its regulation by thrombopoietin (TPO) has emerged. It is now recognized that immune thrombocytopenic purpura (ITP) is a disorder of reduced platelet production as well as increased platelet destruction. New therapies for ITP have emerged that have exploited this new pathophysiologic understanding. This article reviews the biology of TPO, the regulation of its circulating level in ITP, the platelet kinetic data supporting inappropriate platelet production in ITP, and the TPO mimetic agents available to treat ITP.

Citing Articles

Desialylation and Apoptosis in Immune Thrombocytopenia: Implications for Pathogenesis and Treatment.

Zheng S, Perdomo J Curr Issues Mol Biol. 2024; 46(11):11942-11956.

PMID: 39590303 PMC: 11592706. DOI: 10.3390/cimb46110709.

Plasma concentration of thrombopoietin in dogs with immune thrombocytopenia.

Brooks M, Brooks J, Catalfamo J, Zhu Y, Goggs R, Babasyan S J Vet Intern Med. 2024; 38(5):2507-2517.

PMID: 39143652 PMC: 11423463. DOI: 10.1111/jvim.17152.

Antibodies against Platelet Glycoproteins in Clinically Suspected VITT Patients.

Meier R, Porcelijn L, Hofstede-van Egmond S, Caram-Deelder C, Coutinho J, Henskens Y Antibodies (Basel). 2024; 13(2).

PMID: 38804303 PMC: 11130846. DOI: 10.3390/antib13020035.

Pathophysiology, Clinical Manifestations and Diagnosis of Immune Thrombocytopenia: Contextualization from a Historical Perspective.

Martinez-Carballeira D, Bernardo A, Caro A, Soto I, Gutierrez L Hematol Rep. 2024; 16(2):204-219.

PMID: 38651450 PMC: 11036214. DOI: 10.3390/hematolrep16020021.

Current Understanding of Immune Thrombocytopenia: A Review of Pathogenesis and Treatment Options.

Mititelu A, Onisai M, Rosca A, Vladareanu A Int J Mol Sci. 2024; 25(4).

PMID: 38396839 PMC: 10889445. DOI: 10.3390/ijms25042163.

References

Shulman N, WEINRACH R, LIBRE E, ANDREWS H . The role of the reticuloendothelial system in the pathogenesis of idiopathic thrombocytopenic purpura. Trans Assoc Am Physicians. 1965; 78:374-90. View

McIntosh B, Kaushansky K . Transcriptional regulation of bone marrow thrombopoietin by platelet proteins. Exp Hematol. 2008; 36(7):799-806. PMC: 2517608. DOI: 10.1016/j.exphem.2008.02.012. View

McMillan R, Wang L, Tomer A, Nichol J, Pistillo J . Suppression of in vitro megakaryocyte production by antiplatelet autoantibodies from adult patients with chronic ITP. Blood. 2003; 103(4):1364-9. DOI: 10.1182/blood-2003-08-2672. View

Nogami W, Yoshida H, Koizumi K, Yamada H, Abe K, Arimura A . The effect of a novel, small non-peptidyl molecule butyzamide on human thrombopoietin receptor and megakaryopoiesis. Haematologica. 2008; 93(10):1495-504. DOI: 10.3324/haematol.12752. View

Thakur M, Welch M, Joist J, Coleman R . Indium-LLL labeled platelets: studies on preparation and evaluation of in vitro and in vivo functions. Thromb Res. 1976; 9(4):345-57. DOI: 10.1016/0049-3848(76)90135-3. View

Kuter D . New drugs for familiar therapeutic targets: thrombopoietin receptor agonists and immune thrombocytopenic purpura. Eur J Haematol Suppl. 2008; (69):9-18. DOI: 10.1111/j.1600-0609.2007.00999.x. View

Ballmaier M, Germeshausen M, Schulze H, Cherkaoui K, Lang S, Gaudig A . c-mpl mutations are the cause of congenital amegakaryocytic thrombocytopenia. Blood. 2001; 97(1):139-46. DOI: 10.1182/blood.v97.1.139. View

Yang C, Li Y, Kuter D . The physiological response of thrombopoietin (c-Mpl ligand) to thrombocytopenia in the rat. Br J Haematol. 1999; 105(2):478-85. View

Vadhan-Raj S, Kavanagh J, Freedman R, Folloder J, Currie L, Bueso-Ramos C . Safety and efficacy of transfusions of autologous cryopreserved platelets derived from recombinant human thrombopoietin to support chemotherapy-associated severe thrombocytopenia: a randomised cross-over study. Lancet. 2002; 359(9324):2145-52. DOI: 10.1016/S0140-6736(02)09090-6. View

10.

Kuter D, Beeler D, Rosenberg R . The purification of megapoietin: a physiological regulator of megakaryocyte growth and platelet production. Proc Natl Acad Sci U S A. 1994; 91(23):11104-8. PMC: 45175. DOI: 10.1073/pnas.91.23.11104. View

11.

Harker L . Kinetics of thrombopoiesis. J Clin Invest. 1968; 47(3):458-65. PMC: 297192. DOI: 10.1172/JCI105742. View

12.

Peck-Radosavljevic M, Wichlas M, Zacherl J, Stiegler G, Stohlawetz P, Fuchsjager M . Thrombopoietin induces rapid resolution of thrombocytopenia after orthotopic liver transplantation through increased platelet production. Blood. 2000; 95(3):795-801. View

13.

Cole J, Marzec U, Gunthel C, Karpatkin S, Worford L, Sundell I . Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients. Blood. 1998; 91(9):3239-46. View

14.

Harker L . Regulation of thrombopoiesis. Am J Physiol. 1970; 218(5):1376-80. DOI: 10.1152/ajplegacy.1970.218.5.1376. View

15.

Broudy V, Lin N . AMG531 stimulates megakaryopoiesis in vitro by binding to Mpl. Cytokine. 2003; 25(2):52-60. DOI: 10.1016/j.cyto.2003.05.001. View

16.

Frey B, Rafii S, Teterson M, Eaton D, Crystal R, Moore M . Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis. J Immunol. 1998; 160(2):691-9. View

17.

de Sauvage F, Luoh S, Ryan A, Dowd M, Eaton D, Moore M . Physiological regulation of early and late stages of megakaryocytopoiesis by thrombopoietin. J Exp Med. 1996; 183(2):651-6. PMC: 2192470. DOI: 10.1084/jem.183.2.651. View

18.

Ihara K, Ishii E, Eguchi M, Takada H, Suminoe A, GOOD R . Identification of mutations in the c-mpl gene in congenital amegakaryocytic thrombocytopenia. Proc Natl Acad Sci U S A. 1999; 96(6):3132-6. PMC: 15907. DOI: 10.1073/pnas.96.6.3132. View

19.

Kuter D . Thrombopoietin: biology, clinical applications, role in the donor setting. J Clin Apher. 1996; 11(3):149-59. DOI: 10.1002/(SICI)1098-1101(1996)11:3<149::AID-JCA6>3.0.CO;2-B. View

20.

Li J, Yang C, Xia Y, Bertino A, Glaspy J, Roberts M . Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood. 2001; 98(12):3241-8. DOI: 10.1182/blood.v98.12.3241. View